SCHEMBL29949484

SCHEMBL29949484

Cc1cc2ccccc2c(C(N)=O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 4/20 0.44
PARP1 P09874 3/20 0.44
HTT P42858 1/20 0.44
GAA P10253 1/20 0.43
CD38 P28907 3/20 0.42
CYP1A2 P05177 3/20 0.41
CYP2A6 P11509 1/20 0.41
LCK P06239 1/20 0.41
MAP2K3 P46734 1/20 0.41
MAP2K6 P52564 1/20 0.41
BTK Q06187 1/20 0.41
MAP3K19 Q56UN5 1/20 0.41
NEK10 Q6ZWH5 1/20 0.41
NCF1 P14598 1/20 0.41
ELANE P08246 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27844899 0.85 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL4284692 0.84 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL13153171 0.81 KDM4E (0.40) ALDH1A1MEN1KMT2ATP53BLM
SCHEMBL112942 0.80 MAP2K3 (0.46) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL28235893 0.79 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL6274465 0.78 MEN1 (0.40) ALDH1A1MEN1KMT2ATP53BLM
SCHEMBL3205661 0.77 IGFBP3 (0.49) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL5500061 0.76 MAP2K3 (0.57) ALDH1A1MEN1KMT2ATP53KDM4E
SCHEMBL5100092 0.76 LCK (0.47) ALDH1A1MEN1KMT2ATP53KDM4E
SCHEMBL28916905 0.76 SSTR4 (0.45) ALDH1A1KDM4ELMNAPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230045421-A1 SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2023-02-09 US disclosed
CN-115038698-A Thienyl oxazolones and analogs 拜耳公司 2022-09-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230045421-A1 SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME HAVCR2, HMBS, AHCY ALDH1A1 2620/4885MEN1 1955/4885KMT2A 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.